Cargando…

The Modification of Serum Lipids after Acute Coronary Syndrome and Importance in Clinical Practice

Atherosclerosis is a pathology characterized by low-grade vascular inflammation rather than a mere accumulation of lipids. Inflammation is central at all stages of atherosclerosis. Acute coronary syndrome significantly affects the concentration and composition of the lipids and lipoproteins in plasm...

Descripción completa

Detalles Bibliográficos
Autor principal:	Balci, Bahattin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322446/ https://www.ncbi.nlm.nih.gov/pubmed/22758629 http://dx.doi.org/10.2174/157340311799960690

Ejemplares similares

Lipid-Lowering Therapy after Acute Coronary Syndrome in Outpatient Practice—How to Achieve Goal
por: Rajtar-Salwa, Renata, et al.
Publicado: (2023)

Tombstoning ST-Elevation Myocardial Infarction
por: Balci, Bahattin
Publicado: (2009)

Clinical role of serum Copeptin in acute coronary syndrome
por: Abd El Baky Mahmoud, Manal, et al.
Publicado: (2018)

The importance of particular coronary collaterals’ pathway in acute coronary syndrome
por: Alhejily, Wesam A.
Publicado: (2015)

Atypical Presentation of Acute Coronary Syndrome and Importance of Wellens’ Syndrome
por: Kyaw, Kyaw, et al.
Publicado: (2018)

SERUM LEPTIN, ATHEROGENIC LIPIDS AND GLUCOSE LEVELS IN PATIENTS WITH SKIN TAGS
por: Gorpelioglu, Canan, et al.
Publicado: (2009)

Lipidomics of Bioactive Lipids in Acute Coronary Syndromes
por: Solati, Zahra, et al.
Publicado: (2019)

Clinical significance of serum concentrations of neuregulin-4, in acute coronary syndrome
por: Rahimzadeh, Mahsa, et al.
Publicado: (2020)

Prognostic Value of Serum Total Bilirubin after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome
por: Tang, Chengchun, et al.
Publicado: (2019)

Plasma Lipids and Betaine Are Related in an Acute Coronary Syndrome Cohort
por: Lever, Michael, et al.
Publicado: (2011)

Effects of Statin versus the Combination of Ezetimibe plus Statin on Serum Lipid Absorption Markers in Patients with Acute Coronary Syndrome
por: Watanabe, Erisa, et al.
Publicado: (2015)

Antiplatelets in acute coronary syndrome in Poland – from guidelines to clinical practice
por: Tubek, Stanisław, et al.
Publicado: (2021)

Lithium-induced ECG modifications: navigating from acute coronary syndrome to Brugada syndrome
por: Diserens, Léonard, et al.
Publicado: (2021)

Serum Lipids in Turkish Patients with β-Thalassemia Major and β-Thalassemia Minor
por: Işık Balcı, Yasemin, et al.
Publicado: (2016)

Relation of GRACE Risk Score to Coronary Lipid Core Plaques in Patients with Acute Coronary Syndrome
por: Sato, Takanori, et al.
Publicado: (2023)

Changes in Homocysteine Levels Affect Serum Lipid Response to Atorvastatin in Patients With Acute Coronary Syndrome: A Retrospective Observational Study
por: Wu, Dong-Feng, et al.
Publicado: (2020)

Serum Adiponectin and Cardiometabolic Risk in Patients with Acute Coronary Syndromes
por: Oliveira, Gustavo Bernardes de Figueiredo, et al.
Publicado: (2013)

Serum fibrinopeptide A is increased in patients with acute coronary syndrome
por: Yilmaz, Ahmet Seyda, et al.
Publicado: (2023)

GRACE (the Global Registry of Acute Coronary Events): the real world side of the cardiovascular clinical practice in acute coronary syndromes
por: Knobel, M, et al.
Publicado: (2001)

The association between serum anion gap and acute kidney injury after coronary artery bypass grafting in patients with acute coronary syndrome
por: Pan, Qinyuan, et al.
Publicado: (2023)

Religious practices and long-term survival after hospital discharge for an acute coronary syndrome
por: Abu, Hawa O., et al.
Publicado: (2019)

Lipid Management and 2-Year Clinical Outcomes in Japanese Patients with Acute Coronary Syndrome: EXPLORE-J
por: Nakamura, Masato, et al.
Publicado: (2021)

Accelerated Hypertension after Venlafaxine Usage
por: Kıvrak, Yüksel, et al.
Publicado: (2014)

Lipid Management in Patients Presenting With Acute Coronary Syndromes: A Review
por: Claessen, Bimmer E., et al.
Publicado: (2020)

Mast cells and acute coronary syndromes: relationship between serum tryptase, clinical outcome and severity of coronary artery disease
por: Morici, Nuccia, et al.
Publicado: (2016)

Sex-Specific Influence of the SCARB1 Rs5888 SNP on the Serum Lipid Response to Atorvastatin in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Wu, Dong-Feng, et al.
Publicado: (2020)

The Importance of Apneic Events in Obstructive Sleep Apnea Associated with Acute Coronary Syndrome
por: Calcaianu, George, et al.
Publicado: (2019)

Clinical and Economic Analysis of Lipid Goal Attainments in Chinese Patients with Acute Coronary Syndrome Who Received Post-Percutaneous Coronary Intervention
por: Wang, Yun, et al.
Publicado: (2018)

Clinical implications of elevated serum soluble CD137 levels in patients with acute coronary syndrome
por: Yan, Jinchuan, et al.
Publicado: (2013)

Serum Levels of PCSK9 Are Associated with Coronary Angiographic Severity in Patients with Acute Coronary Syndrome
por: Bae, Kwi-Hyun, et al.
Publicado: (2018)

Association of Serum miR-186-5p With the Prognosis of Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention
por: Li, Zhuoling, et al.
Publicado: (2019)

Prospective evaluation of lipid management following acute coronary syndrome in Saudi Arabia
por: Arafah, Mohammed R., et al.
Publicado: (2023)

Clinical Practice Guideline for Cardiac Rehabilitation in Korea: Recommendations for Cardiac Rehabilitation and Secondary Prevention after Acute Coronary Syndrome
por: Kim, Chul, et al.
Publicado: (2019)

Baseline Serum Uric Acid Levels Are Associated with All-Cause Mortality in Acute Coronary Syndrome Patients after Percutaneous Coronary Intervention
por: Ye, Ziliang, et al.
Publicado: (2018)

Improved diagnostic role of CMR in acute coronary syndromes and unobstructed coronary arteries: the importance of time-to-CMR
por: Dastidar, Amardeep Ghosh, et al.
Publicado: (2015)

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention or after acute coronary syndrome: Practical lessons from a review
por: ten Berg, J. M., et al.
Publicado: (2017)

Genetic Heterogeneity in Bartter Syndrome: Clinical and Practical Importance
por: Florea, Laura, et al.
Publicado: (2022)

Optimism and Recovery After Acute Coronary Syndrome: A Clinical Cohort Study
por: Ronaldson, Amy, et al.
Publicado: (2015)

Prevalence of conventional risk factors and lipid profiles in patients with acute coronary syndrome and significant coronary disease
por: González-Pacheco, Héctor, et al.
Publicado: (2014)

An intensive, structured, mobile devices-based healthcare intervention to optimize the lipid-lowering therapy improves lipid control after an acute coronary syndrome
por: Ruiz-Bustillo, Sonia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qkrvsd5plng2g3itq0r23dr07b